Abstract
In rats implanted subcutaneously with morphine containing pellets different degrees of dependence were induced by varying the dosage, frequency of implantation and duration of exposure to morphine. Withdrawal was precipitated by intraperitoneal injection of morphine antagonists, mostly levallorphan. The absorption of morphine from the subcutaneous depots was estimated chemically.
When withdrawal was precipitated with a constant dose of antagonist the frequency of occurrence of various counted signs and the presence of some checked signs were studied in respect to varying degrees of dependence. The results were compared to those obtained after administration of increasing doses of antagonist in groups of animals that had developed a constant degree of dependence.
In both types of experiments the results were rather similar. Some signs became progressively more pronounced when dependence got stronger or the dose of the antagonist was increased. In contrast, other signs showed a maximal frequency at the lower degrees of dependence or after administration of the lower doses of antagonist and decreased or even disappeared when the degree of dependence was higher or the dose of antagonist further increased. Obviously, in withdrawal the intensity of “recessive” signs like writhing and wet dog shaking declines when “dominant” signs like jumping, flying (a vigorous kind of jumping) and teeth chattering increase. An inverse relationship between the occurrence of various signs could also be shown within the 30 min observation period. Changes in the integrative mechanisms controlling behaviour during withdrawal are supposed to be the reason for this shift of signs.
In other experiments in which the interval between each morphine implantation was prolonged the frequency of some signs like jumping and teeth chattering tented to plateau. This finding seems to be correlated to some kind of steady state on resorption of morphine from the subcutaneous depots, as was found in chemical analysis.
Similar content being viewed by others
References
Buckett, W. R.: A new test for morphine-like physical dependence (addiction liability) in rats. Psychopharmacologia (Berl.) 6, 410–416 (1964)
Cheney, D. L., Goldstein, A.: Tolerance to opioid narcotics: time course and reversibility of physical dependence in mice Nature. (Lond.) 232, 471–478 (1971)
Cicero, T. J., Meyer, E. R.: Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence. J. Pharmacol. exp. Ther. 184, 404–408 (1973)
Collier, H. O. J., Francis, D. L., Schneider, C.: Modification of morphine withdrawal by drugs interacting with neuronal mechanisms: some contradictions and their interpretations. Nature (Lond.) 237, 220–223 (1972)
Dewey, W. L., Harris, L. S.: Antinociceptive activity of the narcotic antagonist analgesics and antagonist activity of narcotic analgesics in rodents. J. Pharmacol. exp. Ther. 179, 652–659 (1971)
Francis, D. L., Schneider, C.: Jumping after naloxone precipitated withdrawal of chronic morphine in the rat. Brit. J. Pharmacol. 41, 424P-425P (1971)
Gibson, R. D., Tingstad, J. E.: Formulations of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice. J. pharm. Sci. 59, 426–427 (1970)
Goldstein, A., Sheehan, P.: Tolerance to opioid narcotics. I. Tolerance to the “running fit” caused by levorphanol in the mouse. J. Pharmacol. exp. Ther. 169, 175–183 (1969)
Halbach, H., Eddy, N. B.: Tests for addiction (chronic intoxication) of morphine type. Bull. Wld Hlth Org. 28, 139–173 (1963)
Hoffmeister, F., Schlichting, U.: Einflu\ von Sympathikomimetika, Sympathikolytika, Cholinomimetika und Acetylcholinergika auf das Abstinenzsyndrom von morphinabhÄngigen Ratten In: Schmerz, Grundlagen-Pharmakologie-Therapie, R. Janzen, W. Keidel, A. Herz u. C. Steichele (Hrsg.), pp. 290–294. Stuttgart: Thieme 1972
Huidobro, F., Maggiolo, C.: Some features of the abstinence syndrome to morphine in mice. Acta physiol. lat.-amer. 11, 201–209 (1961)
Kaymakcalan, S., Woods, L. A.: Nalorphine-induced “abstinence syndrome” in morphine tolerant albino rats. J. Pharmacol. exp. Ther. 117, 112–116 (1956)
Kerr, F. W. L., Pozuelo, J.: Suppression of physical dependence and induction of hypersensitivity to morphine by stereotaxic hypothalamic lesions in addicted rats. Proc. Mayo Clin. 46, 653–665 (1971)
Lorenzetti, O. J., Sancilio, L. F.: Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Arch. int. Pharmacodyn. 183, 391–402 (1970)
Maggiolo, C., Huidobro, F.: Administration of pellets of morphine to mice; abstinence syndrome. Acta physiol. lat.-amer. 11, 70–78 (1961)
Marshall, J., Weinstock, M.: Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration. Nature (Lond.) 234, 223–224 (1971)
Marshall, J., Graham-Smith, D. G.: Evidence against a role of brain 5-hydroxy-tryptamine in the development of physical dependence upon morphine in mice. J. Pharmacol. exp. Ther. 173, 634–641 (1971)
Martin, W. R., Wikler, A., Eades, C. G., Pescor, F. T.: Tolerance to and physical dependence on morphine in rats. Psychopharmacologia (Berl.) 4, 247–260 (1963)
Takemori, A. E., Maruyama, Y.: The role of biogenic amines in the naloxone-induced withdrawal of morphine-dependent mice. Fed. Proc. 31, 1642 (1972)
Way, E. L., Loh, H. H., Shen, F.: Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. exp. Ther. 167, 1–8 (1969)
Wei, E.: Assessment of precipitated abstinence in morphine-dependent rats. Psychopharmacologia (Berl.) 28, 35–44 (1973)
Wei, E., Horace, H. L., Way, E. L.: Quantitative aspects of precipitated abstinence in morphine-dependent rats. J. Pharmacol. exp. Ther. 184, 398–403 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BlÄsig, J., Herz, A., Reinhold, K. et al. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33, 19–38 (1973). https://doi.org/10.1007/BF00428791
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00428791